Oral Yeast Colonization and Fungal Infections in Peritoneal Dialysis Patients: A Pilot Study

Liliana Simões-Silva1,2,3, Sara Silva4, Carla Santos-Araujo5,6

  • 1i3S-Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal.

Insights

Oral yeast colonization in peritoneal dialysis patients is less common than in healthy individuals. This pilot study found no link between oral yeast and subsequent fungal infections in PD patients, suggesting a limited risk.

Area of Science:

  • Medical Mycology
  • Infectious Diseases
  • Nephrology

Background:

  • Peritonitis and exit-site infections are significant complications for patients undergoing peritoneal dialysis (PD).
  • Opportunistic fungi from distant body sites can cause these infections.
  • Understanding the role of oral yeast colonization in PD patients is crucial for infection prevention.

Purpose of the Study:

  • To investigate oral yeast colonization prevalence in PD patients compared to healthy controls.
  • To determine the antifungal susceptibility profiles of isolated oral yeasts.
  • To correlate oral yeast colonization with subsequent fungal infection episodes in PD patients over four years.

Main Methods:

  • Saliva samples from 21 PD patients and 27 healthy controls were analyzed for yeast colonization.
  • Methods included CHROMagar-Candida® growth and 18S rRNA/ITS sequencing.
  • Antifungal susceptibility testing was performed on isolated yeast species.

Main Results:

  • PD patients showed lower oral yeast prevalence, particularly for Candida albicans, compared to controls.
  • Isolated species included Candida glabrata and Candida carpophila, with notable antifungal resistance patterns.
  • No correlation was found between oral yeast colonization and PD-related exit-site infections caused by Candida parapsilosis and Candida zeylanoides.

Conclusions:

  • Oral yeast colonization appears to pose a limited risk for fungal infections in PD patients.
  • Isolated oral yeasts exhibited variable antifungal susceptibility, indicating potential resistance to certain drugs.
  • Antifungal susceptibility assessment is important in clinical practice for PD patients.

Related Concept Videos

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications01:25

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
917
Peritoneal Dialysis I: Introduction and Procedure01:30

Peritoneal Dialysis I: Introduction and Procedure

Peritoneal dialysis (PD) is a procedure that facilitates the exchange of solutes, waste products, electrolytes, and excess fluid between the blood in the peritoneal capillaries and a dialysis solution introduced into the peritoneal cavity.Principles of Peritoneal Dialysis (PD)Diffusion: Waste products such as urea and electrolytes move from high concentrations in the blood to low concentrations in the dialysate across the peritoneal membrane. This mechanism is driven by the concentration...
3.6K
Peritoneal Dialysis III: Nursing Management01:25

Peritoneal Dialysis III: Nursing Management

Peritoneal dialysis, or PD, utilizes the peritoneal membrane as a filter to eliminate excess fluid and waste products. Effective nursing management is essential for ensuring patient safety, preventing complications, and promoting optimal function of the peritoneal dialysis process.Assessment and MonitoringNurses must thoroughly assess the patient before, during, and after each dialysis session. Regular monitoring includes vital signs, daily weight, fluid intake and output, and laboratory values...
929
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis01:30

Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis

Patients with end-stage renal disease (ESRD) or those experiencing drug overdose often require extracorporeal methods to eliminate accumulated drugs and metabolites. Hemoperfusion, hemofiltration, and dialysis are the primary techniques to rapidly remove harmful substances without disrupting the patient's fluid and electrolyte balance. For those with compromised renal function, dosage adjustments of concurrent medications may be necessary during extracorporeal drug removal.Dialysis is a process...
561
Dialysis01:27

Dialysis

Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
1.5K
Dialysis01:15

Dialysis

Dialysis is a diffusion-based purification process that separates analyte molecules from a complex matrix. This is accomplished by allowing molecules in the solution to pass through a semipermeable membrane into a liquid on the other side. The membrane is usually made of cellulose acetate or cellulose nitrate, and the second liquid must be miscible with the solution. Ions (e.g., chloride or sodium) or organic molecules (e.g., glucose) can pass through the membrane pores, which generally have...
1.9K